BaySize: Bayesian Sample Size Planning for Phase I Dose-Finding Trials

03/11/2021
by   Xiaolei Lin, et al.
0

We propose BaySize, a sample size calculator for phase I clinical trials using Bayesian models. BaySize applies the concept of effect size in dose finding, assuming the MTD is defined based on an equivalence interval. Leveraging a decision framework that involves composite hypotheses, BaySize utilizes two prior distributions, the fitting prior (for model fitting) and sampling prior (for data generation), to conduct sample size calculation under desirable statistical power. Look-up tables are generated to facilitate practical applications. To our knowledge, BaySize is the first sample size tool that can be applied to a broad range of phase I trial designs.

READ FULL TEXT

page 19

page 21

page 22

page 23

page 24

page 29

page 30

page 31

research
12/29/2020

Sample Size Re-estimation Design in Phase II Dose Finding Study with Multiple Dose Groups: Frequentist and Bayesian Methods

Unblinded sample size re-estimation (SSR) is often planned in a clinical...
research
07/03/2019

A Bayesian decision-theoretic approach to incorporate preclinical information into phase I oncology trials

Leveraging preclinical animal data for a phase I first-in-man trial is a...
research
12/09/2020

Objective Bayesian approach to the Jeffreys-Lindley paradox

We consider the Jeffreys-Lindley paradox from an objective Bayesian pers...
research
10/20/2020

Hi3+3: A Model-Assisted Dose-Finding Design Borrowing Historical Data

Background – In phase I clinical trials, historical data may be availabl...
research
06/28/2020

A review of Bayesian perspectives on sample size derivation for confirmatory trials

Sample size derivation is a crucial element of the planning phase of any...
research
11/05/2017

Likelihood Based Study Designs for Time-to-Event Endpoints

Likelihood methods for measuring statistical evidence obey the likelihoo...

Please sign up or login with your details

Forgot password? Click here to reset